CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Veterinary pharmacovigilance in the United Kingdom

Open-knowledge reference entry

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionOct 27, 2024
Entity authorityQ7649164 ↗
Source-derived summary

Veterinary pharmacovigilance in the United Kingdom is overseen by the Veterinary Medicines Directorate (VMD).

Overview

The Pharmacovigilance Unit at the VMD monitors adverse events; the monitoring carried out by this unit was previously known as the Suspect Adverse Reaction Surveillance Scheme, and is similar to the Yellow Card Scheme of pharmacovigilance for human medicine. The Pharmacovigilance Unit gathers information about suspected adverse events to veterinary medicines in both animals and humans, including suspected lack of expected efficacy, environmental problems, residues in foodstuffs. Anyone, including animal owners, can report suspected adverse events to the VMD, although veterinary surgeons submit most reports.

The marketing authorisation holder of a medicine, that is, the company that has the licence for the medicine, is legally obliged to inform the VMD of any adverse events which are reported to them. The following must be reported by marketing authorisation holders within 15 days:

Serious SAEs (suspected adverse events that result in death, are life-threatening, results in significant disability or incapacity, are a congenital anomaly/birth defect, or that results in permanent or prolonged signs in the animals treated)

Human adverse reactions (a reaction that is noxious and unintended and that occurs in a human being following exposure to a veterinary medicine)

Unintended transmission of an infectious agent through a veterinary medicinal product

All other adverse events must be reported in a Periodic Safety Update Report. All SAEs (to animals and humans) should be reported by veterinary surgeons as this is considered good professional conduct (RCVS Guide to Professional Conduct).

Reporters can submit reports online. Hard copies of the reporting forms can also be requested from the VMD or downloaded and printed from the website.

The reports are monitored and analysed by the Pharmacovigilance team of the VMD, who make reports to the Veterinary Products Committee.

Editorial summary

The public source identifies “Veterinary pharmacovigilance in the United Kingdom” as open-knowledge reference entry. This brief keeps that definition visible, then builds a research path around Veterinary, pharmacovigilance and United.

Editorial reviewA concise reference frame for defining the subject, testing terminology and identifying the institution closest to the evidence. The current 297-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Veterinary, pharmacovigilance and United providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Veterinary pharmacovigilance in the United Kingdom”, the useful work is to connect “open-knowledge reference entry” to the records capable of establishing context and consequence.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Oct 27, 2024. The linked authority identifier is Q7649164. None of the 0 selected statements returned an explicit reference.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Veterinary pharmacovigilance in the United Kingdom”, its source revision and the description used here.
  2. Expand the search: follow Veterinary pharmacovigilance in the United Kingdom primary sources, Veterinary pharmacovigilance in the United Kingdom archive and Veterinary research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Veterinary pharmacovigilance in the United Kingdom”?
  2. What terminology or title could unlock a more precise catalogue search?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from “Veterinary pharmacovigilance in the United Kingdom” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.